Literature DB >> 2677935

Developmental pharmacology: ontogenic basis of drug disposition.

M D Reed1, J B Besunder.   

Abstract

Our understanding of clinical pharmacology in pediatrics, although limited, is continually increasing. This increase in our database reflects the supportive perspective of our colleagues, but more importantly, the recognition that specific pharmacokinetic and pharmacodynamic data in children are necessary for the provision of optimal care. In this review, we have focused on the many predictable influences of body maturation on drug disposition. These data underscore the importance of the many patient-specific variables that directly influence a patient's clinical response to drugs and, thus, the design of appropriate pharmacotherapeutic regimens.

Entities:  

Mesh:

Year:  1989        PMID: 2677935     DOI: 10.1016/s0031-3955(16)36757-8

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  9 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.

Authors:  M D Reed; T S Yamashita; C K Knupp; J M Veazey; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 3.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

4.  Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model.

Authors:  Khaled Abduljalil; Masoud Jamei; Amin Rostami-Hodjegan; Trevor N Johnson
Journal:  AAPS J       Date:  2014-04-04       Impact factor: 4.009

5.  Insufficient ketoconazole concentrations in preterm infants with fungal infections.

Authors:  J N van den Anker; R A van Lingen; M Koster; J Heykants; P J Sauer
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

6.  Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.

Authors:  Andreas H Groll; Lauren Wood; Maureen Roden; Diana Mickiene; Christine C Chiou; Ellen Townley; Luqman Dad; Stephen C Piscitelli; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 7.  Paediatric labelling requirements. Implications for pharmacokinetic studies.

Authors:  J T Wilson; G L Kearns; D Murphy; S J Yaffe
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

8.  Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimization.

Authors:  Michael Neely; Roger Jelliffe
Journal:  J Clin Pharmacol       Date:  2008-07-17       Impact factor: 3.126

9.  Pharmacokinetic characteristics of caspofungin in two pediatric liver transplant patients.

Authors:  Michael Neely; Jeffrey Blumer
Journal:  Curr Ther Res Clin Exp       Date:  2003-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.